MedTronic - What is your Opinion? Shall we discuss it?
Actualizado
This time as an experiment, why don't we discuss the prospects before taking action-
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability does it not?
Proactive identification: Medtronic identified the cybersecurity vulnerability in their Paceart Optima system during routine monitoring.
Prompt reporting: The company reported the issue to the U.S. Cybersecurity & Infrastructure Security Agency (CISA).
Transparency: Medtronic issued a security bulletin and provided information about the vulnerability.
Rapid response: The company developed and released an update (v1.12) to address the vulnerability.
Customer communication: Medtronic notified healthcare organizations about the issue and provided instructions to eliminate the vulnerability.
Commitment to security: The company stated they take potential cybersecurity vulnerabilities very seriously.
Vulnerabilities:
Critical flaw in Paceart Optima system: The vulnerability (CVE-2023-31222) has a critical CVSS score of 9.8 out of 1035.
Remote code execution risk: If exploited, the vulnerability could allow unauthorized users to perform remote code execution or launch denial-of-service attacks.
Data compromise: Hackers could potentially delete, steal, or modify cardiac device data.
Network penetration: The vulnerability could be used as a gateway for further network penetration in healthcare organizations.
Legacy devices: The issue affects older versions of the software (v1.11 and earlier), highlighting the need for regular updates.
Optional feature risk: The vulnerability exists in an optional messaging feature, which if enabled, exposes the system to potential attacks.
Historical vulnerabilities: Medtronic has faced previous scrutiny for security issues in other devices, such as insulin pumps and defibrillators.
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability does it not?
Proactive identification: Medtronic identified the cybersecurity vulnerability in their Paceart Optima system during routine monitoring.
Prompt reporting: The company reported the issue to the U.S. Cybersecurity & Infrastructure Security Agency (CISA).
Transparency: Medtronic issued a security bulletin and provided information about the vulnerability.
Rapid response: The company developed and released an update (v1.12) to address the vulnerability.
Customer communication: Medtronic notified healthcare organizations about the issue and provided instructions to eliminate the vulnerability.
Commitment to security: The company stated they take potential cybersecurity vulnerabilities very seriously.
Vulnerabilities:
Critical flaw in Paceart Optima system: The vulnerability (CVE-2023-31222) has a critical CVSS score of 9.8 out of 1035.
Remote code execution risk: If exploited, the vulnerability could allow unauthorized users to perform remote code execution or launch denial-of-service attacks.
Data compromise: Hackers could potentially delete, steal, or modify cardiac device data.
Network penetration: The vulnerability could be used as a gateway for further network penetration in healthcare organizations.
Legacy devices: The issue affects older versions of the software (v1.11 and earlier), highlighting the need for regular updates.
Optional feature risk: The vulnerability exists in an optional messaging feature, which if enabled, exposes the system to potential attacks.
Historical vulnerabilities: Medtronic has faced previous scrutiny for security issues in other devices, such as insulin pumps and defibrillators.
Orden cancelada
I hear they could fce a lot of litigation. from pace makers and radio frequency interference = just watching it for now 
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.